BANGKOK (The Nation/ANN): The Food and Drug Administration (FDA) has approved for use in Thailand Favipiravir tablets -- administered to Covid-19 patients -- researched, developed and manufactured by the Government Pharmaceutical Organisation (GPO).
“The GPO will start manufacturing Favipiravir tablets in August and will start delivering to hospitals immediately,” Dr Nanthakan Suwanpidokkul, a drug specialist at GPO, said on Thursday (July 15).
Already a subscriber? Log in.
Limited time offer:
Just RM5 per month.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!